Status:

UNKNOWN

VSL#3 Treatment in Children With Crohn's Disease

Lead Sponsor:

Hadassah Medical Organization

Conditions:

Crohn's Disease

Eligibility:

All Genders

6-18 years

Phase:

PHASE4

Brief Summary

Crohn's disease (CD) in childhood is a chronic relapsing and remitting condition that has a significant impact on growth and development. The disease is characterized by an increased and unregulated i...

Detailed Description

The aim of this study is to compare probiotic therapy with VSL#3 versus placebo in maintenance therapy of children with mild to moderate CD, treated with either 5-ASA, corticosteroids (local or budeso...

Eligibility Criteria

Inclusion

  • Children aged 6 - 18 years
  • Previous diagnosis of Crohn's disease or newly diagnosed with symptoms for at least three months before recruitment to the study.The diagnosis of CD is established by:
  • history and symptoms of the disease
  • endoscopy/histology or radiology with negative stool culture.
  • Written informed consent by parent
  • PCDAI \> 12.5 and \< 30
  • Treatment with 5-ASA, budesonide and imuran/6MP daily provided that the dose has remained stable for the 4 weeks (corticosteroids) or 12 weeks (for imuran/6MP) prior to inclusion. Children treated with other medications (such as anti-TNF or antibiotics including ciprofloxacilin or metronidazole) cannot enter this study.

Exclusion

  • Short bowel syndrome/ileostomy/abscess/fistula/small bowel obstruction/stenosis/stricture
  • Imminent surgery
  • Treatment with anti-TNF, systemic corticosteroids, ciprofloxacillin, metronidazole within 12 weeks of the start of the trial.
  • Participation in another clinical trial within the last 30 days.
  • Patients should not take antibiotics during the study.
  • Patients should not take opioids, cholestyramine, ursodeoxycholic acid during the study.

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2010

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00367705

Start Date

August 1 2009

End Date

December 1 2010

Last Update

August 18 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hadassah Medical Organization,

Jerusalem, Israel, 91120